Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia

Schizophrenia Research

Volumn 101, Issue 1-3, 2008, Pages 304-311

  dosReis, Susan ^a,b   Johnson, Elizabeth ^b   Steinwachs, Donald ^b   Rohde, Charles ^b   Skinner, Elizabeth A ^b   Fahey, Maureen ^b   Lehman, Anthony F ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic use; Longitudinal analysis; Medicaid; Schizophrenia; Severe mental illness

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COMMUNITY ASSESSMENT; CONFIDENCE INTERVAL; DEMOGRAPHY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAID; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALIZATION; HUMANS; MALE; MARYLAND; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 42749089935     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.12.475     Document Type: Article

References (31)

1. APA. 1997. Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association (APA). American Journal of Psychiatry 154(4 (Suppl)):1-63.
2. Ascione F.J., Brown G.H., and Kirking D.M. Evaluation of a medication refill reminder system for a community pharmacy. Patient Education and Counseling 7 2 (1985) 157-165
3. Bagchi A., Sambamoorthi U., McSpiritt E., Yanos P., Walkup J., and Crystal S. Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophrenia Research 71 2-3 (2004) 435-444
4. dosReis S., Zito J.M., Buchanan R.W., and Lehman A.F. Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia. Schizophrenia Bulletin 28 4 (2002) 607-617
5. Fleck D.E., Hendricks W.L., DelBello M.P., and Strakowski S.M. Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder. Journal of Clinical Psychiatry 63 8 (2002) 658-664
6. Gilmer T.P., Dolder C.R., Lacro J.P., Folsom D.P., Lindamer L., Garcia P., and Jeste D.V. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161 4 (2004) 692-699
7. Herz M.I., Glazer W.M., Mostert M.A., Sheard M.A., Szymanski H.V., Hafez H., Mirza M., and Vana J. Intermittent vs maintenance medication in schizophrenia. Two-year results. Archives of General Psychiatry 48 4 (1991) 333-339
8. Kilbourne A.M., and Pincus H.A. Patterns of psychotropic medication use by race among veterans with bipolar disorder. Psychiatric Services 57 1 (2006) 123-126
9. Kreyenbuhl J., Zito J.M., Buchanan R.W., Soeken K.L., and Lehman A.F. Racial disparity in the pharmacological management of schizophrenia. Schizophrenia Bulletin 29 2 (2003) 183-193
10. Lehman A.F., Kreyenbuhl J., Buchanan R.W., Dickerson F.B., Dixon L.B., Goldberg R., Green-Paden L.D., Tenhula W.N., Boerescu D., Tek C., et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophrenia Bulletin 30 2 (2004) 193-217
11. Lehman A.F., Steinwachs D.M., and Co-Investigators of the PORT Project. At issue: translating research into practice: the schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24 1 (1998) 1-10
12. Lehman A.F., Thompson J.W., Dixon L.B., and Scott J.E. Schizophrenia: treatment outcomes research. Schizophrenia Bulletin 21 4 (1995) 561-566
13. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353 12 (2005) 1209-1223
14. Mallinger J.B., Fisher S.G., Brown T., and Lamberti J.S. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatric Services 57 1 (2006) 133-136
15. McCombs J.S., Nichol M.B., Johnstone B.M., Stimmel G.L., Shi J., and Smith R. Antipsychotic drug use patterns and the cost of treating schizophrenia. Psychiatric Services 51 4 (2000) 525-527
16. McCombs J.S., Nichol M.B., Stimmel G.L., Shi J., and Smith R.R. Use patterns for antipsychotic medications in Medicaid patients with schizophrenia. Journal of Clinical Psychiatry 60 Suppl 19 (1999) 5-11
17. Menzin J., Boulanger L., Friedman M., Mackell J., and Lloyd J.R. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatric Services 54 5 (2003) 719-723
18. Mojtabai R., Lavelle J., Gibson P.J., Sohler N.L., Craig T.J., Carlson G.A., and Bromet E.J. Gaps in the use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989-1996. Psychiatric Services 53 3 (2002) 337-339
19. Olfson M., Marcus S.C., Wilk J., and West J.C. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatric Services 57 2 (2006) 205-211
20. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56 3 (1999) 241-247
21. Schooler N.R. Relapse prevention and recovery in the treatment of schizophrenia. Journal of Clinical Psychiatry 67 Suppl 5 (2006) 19-23
22. Schulz R.M., and Gagnon J.P. Patient behavior patterns regarding prescription refills. Contemporary Pharmacy Practice 5 3 (1982) 150-155
23. Trifiro G., Spina E., Brignoli O., Sessa E., Caputi A.P., and Mazzaglia G. Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. European Journal of Clinical Pharmacology 61 1 (2005) 47-53
24. Valenstein M., Blow F.C., Copeland L.A., McCarthy J.F., Zeber J.E., Gillon L., Bingham C.R., and Stavenger T. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophrenia Bulletin 30 2 (2004) 255-264
25. Valenstein M., Copeland L.A., Blow F.C., McCarthy J.F., Zeber J.E., Gillon L., Bingham C.R., and Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40 8 (2002) 630-639
26. Vanelli M., Burstein P., and Cramer J. Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain. Psychiatric Services 52 9 (2001) 1248-1250
27. Velligan D.I., Lam F., Ereshefsky L., and Miller A.L. Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services 54 5 (2003) 665-667
28. Verdoux H., Lengronne J., Liraud F., Gonzales B., Assens F., Abalan F., and van Os J. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica 102 3 (2000) 203-210
29. Weiden P.J., Kozma C., Grogg A., and Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55 8 (2004) 886-891
30. Williams C.L., Johnstone B.M., Kesterson J.G., Javor K.A., and Schmetzer A.D. Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia. Medical Care 37 4 (1999) AS81-AS86
31. Yang J., Law S., Chow W., Andermann L., Steinberg R., and Sadavoy J. Best practices: assertive community treatment for persons with severe and persistent mental illness in ethnic minority groups. Psychiatric Services 56 9 (2005) 1053-1055